The Recall Desk

Manufacturer

Cubist Pharmaceuticals, Inc.

4 recalls in our database name Cubist Pharmaceuticals, Inc. as the manufacturing or recalling firm.

What the numbers show

Total
4
Critical
0
Severe
3
Most recent
2014-11-05

Of the 4 recalls from Cubist Pharmaceuticals, Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 3 (75%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–4 of 4

  • SevereFDA (Drugs)·D-0229-2015·2014-11-05

    Cubicin Injection Recalled for Foreign Particulate Matter in Vials

    Cubist Pharmaceuticals is recalling Cubicin (daptomycin) injection vials due to the presence of tiny black foreign particulate matter observed after reconstitution.

    Product
    CUBICIN (daptomycin for injection) 500 mg, For Intravenous Use Only, Rx Only, Single use Vial, Manufactured for: Cubist Pharmaceuticals Inc., Lexington, MA 02421, USA, NDC 67919-011-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0001-2015·2014-10-08

    CUBICIN daptomycin injection vials recalled due to potential glass particulate matter

    The FDA is recalling CUBICIN daptomycin injection vials because there may be glass particles present in the vials.

    Product
    CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, NDC 67919-011-01, UPC 3 67919-011-01 6.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1382-2014·2014-06-18

    Cubist Recalls CUBICIN Vials Due to Glass Shard Presence

    Cubist Pharmaceuticals is recalling 51,500 vials of CUBICIN (daptomycin) because a customer reported a glass shard in one vial.

    Product
    CUBICIN (daptomycin for injection), 500 mg single-use vial, Rx only, Manufactured for: Cubist Pharmaceuticals, Inc., Lexington, MA 02421, NDC 67919-011-01, UPC 3 67919-011-01 6.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-764-2014·2014-01-29

    Cubicin Injection Recalled for Glass Particulates in Vials

    Cubist Pharmaceuticals is recalling 179,870 vials of Cubicin (daptomycin for injection) due to the presence of glass particulates.

    Product
    Cubicin (daptomycin for injection), 500 mg lyophilized powder, 10 mL single-use vials, Rx only, Manufactured for Cubist Pharmaceuticals, Inc., Lexington, MA
    Category
    Drug
    Distribution
    Distributed nationwide

About this company

Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.

Cubist Pharmaceuticals

defunct American pharmaceutical company

Country
United States
Founded
1992

Official website

Source: Wikidata (Q5192265), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.